|
1
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Z, Li C, Liu C, Yu S and Zhang Y:
Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in
non-functioning pituitary adenomas and their relationship to tumor
behavior. Pituitary. 18:42–47. 2015. View Article : Google Scholar
|
|
4
|
Miyoshi N, Wagatsuma H, Wakana S,
Shiroishi T, Nomura M, Aisaka K, Kohda T, Surani MA, Kaneko-Ishino
T and Ishino F: Identification of an imprinted gene, Meg3/Gtl2 and
its human homologue MEG3, first mapped on mouse distal chromosome
12 and human chromosome 14q. Genes Cells. 5:211–220. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bando T, Kato Y, Ihara Y, Yamagishi F,
Tsukada K and Isobe M: Loss of heterozygosity of 14q32 in
colorectal carcinoma. Cancer Genet Cytogenet. 111:161–165. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu
WQ, Xie WP and Hou YY: Long non-coding RNA MEG3 inhibits NSCLC
cells proliferation and induces apoptosis by affecting p53
expression. BMC Cancer. 13:4612013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Braconi C, Kogure T, Valeri N, Huang N,
Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM and Patel T:
microRNA-29 can regulate expression of the long non-coding RNA gene
MEG3 in hepatocellular cancer. Oncogene. 30:4750–4756. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang X, Gejman R, Mahta A, Zhong Y, Rice
KA, Zhou Y, Cheunsuchon P, Louis DN and Klibanski A: Maternally
expressed gene 3, an imprinted noncoding RNA gene, is associated
with meningioma pathogenesis and progression. Cancer Res.
70:2350–2358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu LX, Deng W, Zhou XT, Chen RP, Xiang
MQ, Guo YT, Pu ZJ, Li R, Wang GF and Wu LF: The mechanism of
adenosine-mediated activation of lncRNA MEG3 and its antitumor
effects in human hepatoma cells. Int J Oncol. 48:421–429. 2016.
|
|
11
|
Schröder M: Endoplasmic reticulum stress
responses. Cell Mol Life Sci. 65:862–894. 2008. View Article : Google Scholar
|
|
12
|
Wu LF, Ye YQ, Huang GY, Li HB, Li GP, Pu
ZJ, Wei BL and Feng JL: Involvement of endoplasmic reticulum stress
in adenosine-induced human hepatoma HepG2 cell apoptosis. Oncol
Rep. 26:73–79. 2011.PubMed/NCBI
|
|
13
|
Giampietri C, Petrungaro S, Conti S,
Facchiano A, Filippini A and Ziparo E: Cancer microenvironment and
endoplasmic reticulum stress response. Mediators Inflamm.
2015:4172812015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu LF, Guo YT, Zhang QH, Xiang MQ, Deng W,
Ye YQ, Pu ZJ, Feng JL and Huang GY: Enhanced antitumor effects of
adenoviral-mediated siRNA against GRP78 gene on adenosine-induced
apoptosis in human hepatoma HepG2 cells. Int J Mol Sci. 15:525–544.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zinszner H, Kuroda M, Wang X, Batchvarova
N, Lightfoot RT, Remotti H, Stevens JL and Ron D: CHOP is
implicated in programmed cell death in response to impaired
function of the endoplasmic reticulum. Genes Dev. 12:982–995. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakagawa T, Zhu H, Morishima N, Li E, Xu
J, Yankner BA and Yuan J: Caspase-12 mediates
endoplasmic-reticulum-specific apoptosis and cytotoxicity by
amyloid-beta. Nature. 403:98–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Urano F, Wang X, Bertolotti A, Zhang Y,
Chung P, Harding HP and Ron D: Coupling of stress in the ER to
activation of JNK protein kinases by transmembrane protein kinase
IRE1. Science. 287:664–666. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou Y, Zhong Y, Wang Y, Zhang X, Batista
DL, Gejman R, Ansell PJ, Zhao J, Weng C and Klibanski A: Activation
of p53 by MEG3 non-coding RNA. J Biol Chem. 282:24731–24742. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang PM, Lin YT, Shun CT, Lin SH, Wei TT,
Chuang SH, Wu MS and Chen CC: Zebularine inhibits tumorigenesis and
stemness of colorectal cancer via p53-dependent endoplasmic
reticulum stress. Sci Rep. 3:32192013.PubMed/NCBI
|
|
20
|
Kilkenny C, Browne W, Cuthill IC, Emerson
M and Altman DG; NC3Rs Reporting Guidelines Working Group: Animal
research: Reporting in vivo experiments: The ARRIVE guidelines. Br
J Pharmacol. 160:1577–1579. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee AS: The ER chaperone and signaling
regulator GRP78/BiP as a monitor of endoplasmic reticulum stress.
Methods. 35:373–381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bromati CR, Lellis-Santos C, Yamanaka TS,
Nogueira TC, Leonelli M, Caperuto LC, Gorjão R, Leite AR, Anhê GF
and Bordin S: UPR induces transient burst of apoptosis in islets of
early lactating rats through reduced AKT phosphorylation via
ATF4/CHOP stimulation of TRB3 expression. Am J Physiol Regul Integr
Comp Physiol. 300:R92–R100. 2011. View Article : Google Scholar
|
|
23
|
Wu H and Lozano G: NF-kappa B activation
of p53. A potential mechanism for suppressing cell growth in
response to stress. J Biol Chem. 269:20067–20074. 1994.PubMed/NCBI
|
|
24
|
Furlong EE, Rein T and Martin F: YY1 and
NF1 both activate the human p53 promoter by alternatively binding
to a composite element, and YY1 and E1A cooperate to amplify p53
promoter activity. Mol Cell Biol. 16:5933–5945. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kitamura M: Control of NF-κB and
inflammation by the unfolded protein response. Int Rev Immunol.
30:4–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kaneko M, Niinuma Y and Nomura Y:
Activation signal of nuclear factor-kappa B in response to
endoplasmic reticulum stress is transduced via IRE1 and tumor
necrosis factor receptor-associated factor 2. Biol Pharm Bull.
26:931–935. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang HY, Wek SA, McGrath BC, Scheuner D,
Kaufman RJ, Cavener DR and Wek RC: Phosphorylation of the alpha
subunit of eukaryotic initiation factor 2 is required for
activation of NF-kappaB in response to diverse cellular stresses.
Mol Cell Biol. 23:5651–5663. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamazaki H, Hiramatsu N, Hayakawa K,
Tagawa Y, Okamura M, Ogata R, Huang T, Nakajima S, Yao J, Paton AW,
et al: Activation of the Akt-NF-kappaB pathway by subtilase
cytotoxin through the ATF6 branch of the unfolded protein response.
J Immunol. 183:1480–1487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu J, Liu S, Ye F, Shen Y, Tie Y, Zhu J,
Wei L, Jin Y, Fu H, Wu Y, et al: Long noncoding RNA MEG3 interacts
with p53 protein and regulates partial p53 target genes in hepatoma
cells. PLoS One. 10:e01397902015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu L, Pu Z, Feng J, Li G, Zheng Z and Shen
W: The ubiquitin-proteasome pathway and enhanced activity of
NF-kappaB in gastric carcinoma. J Surg Oncol. 97:439–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu LF, Li GP, Su JD, Pu ZJ, Feng JL, Ye YQ
and Wei BL: Involvement of NF-kappaB activation in the apoptosis
induced by extracellular adenosine in human hepatocellular
carcinoma HepG2 cells. Biochem Cell Biol. 88:705–714. 2010.
View Article : Google Scholar : PubMed/NCBI
|
